MS

Muhammed Sufiyan Kaniya Thodi

Active Director Director DIN 10924648
DIN 10924648 First appointment Jan 2025 Primary industry Professional Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Muhammed Sufiyan Kaniya Thodi

Data last updated:

Muhammed Sufiyan Kaniya Thodi is a Director at Arog Medeco Private Limited (since 2025). The company operates in Professional Services.

DIN 10924648
Primary Designation Director
Industry Professional Services
First Appointment 27 Jan 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Arog Medeco Private Limited U72100KL2025PTC091670
Director27 Jan 20252025Active

Board colleagues of Muhammed Sufiyan Kaniya Thodi

NameDINCompanyDesignation
Raja Thashreef P R10924647Arog Medeco Private LimitedDirector

Directorship timeline

Open interactive timeline →
Arog Medeco Private Limited
Premium access

Shareholding and investment profile for Muhammed Sufiyan Kaniya Thodi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Muhammed Sufiyan Kaniya Thodi

Muhammed Sufiyan Kaniya Thodi currently holds 1 directorship: Arog Medeco Private Limited (Director, since 27 Jan 2025).

Muhammed Sufiyan Kaniya Thodi was first appointed on 27 Jan 2025 as Director at Arog Medeco Private Limited.

The current boards of Muhammed Sufiyan Kaniya Thodi's companies include Raja Thashreef P R (Arog Medeco Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available